Related Experiment Video
Updated: Mar 22, 2026

12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
47.5K
Catastrophic cliffs: a partial suggestion for selective vulnerability in neurodegenerative diseases
1Reta Lila Weston Research Laboratories, UCL Institute of Neurology, Queen Square, London WC1N3BG, U.K. j.hardy@ucl.ac.uk.
Biochemical Society Transactions
|April 13, 2016
Summary
Neurodegenerative diseases show selective vulnerability due to specific neuronal type weaknesses. Understanding genetic risk loci helps reveal how different neuron types fail catastrophically.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Neurodegenerative diseases are linked to numerous genetic risk loci.
- Understanding the specific genetic underpinnings is crucial for disease research.
Purpose of the Study:
- To explore how genetic risk loci inform neuronal vulnerabilities.
- To propose that distinct neuronal types have unique failure modes.
Main Methods:
- Review and synthesis of existing genetic data for neurodegenerative syndromes.
- Conceptual framework development linking genetic loci to neuronal vulnerability.
Main Results:
- Identification of numerous pathogenic and causative genetic risk loci across neurodegenerative syndromes.
- Hypothesis that specific neuronal types exhibit differential vulnerabilities.
Conclusions:
- Genetic knowledge enables understanding of neuronal type-specific vulnerabilities.
- Differential neuronal failure modes contribute to selective vulnerability in neurodegenerative diseases.
Related Concept Videos
Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia
672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
672
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.7K

